With the clock ticking on monthly goserelin, the gonadotrophin-releasing hormone agonist could help fill a looming gap in subsidised care.
End of content
No more pages to load
With the clock ticking on monthly goserelin, the gonadotrophin-releasing hormone agonist could help fill a looming gap in subsidised care.
End of content
No more pages to load